Burra P - Search Results

1

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.

Schnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, de Jong KP, Duvoux C, Kneteman NM, Adam R, Bechstein WO, Becker T, Beckebaum S, Chazouillères O, Cillo U, Colledan M, Fändrich F, Gugenheim J, Hauss JP, Heise M, Hidalgo E, Jamieson N, Königsrainer A, Lamby PE, Lerut JP, Mäkisalo H, Margreiter R, Mazzaferro V, Mutzbauer I, Otto G, Pageaux GP, Pinna AD, Pirenne J, Rizell M, Rossi G, Rostaing L, Roy A, Turrion VS, Schmidt J, Troisi RI, van Hoek B, Valente U, Wolf P, Wolters H, Mirza DF, Scholz T, Steininger R, Soderdahl G, Strasser SI, Jauch KW, Neuhaus P, Schlitt HJ, Geissler EK. Schnitzbauer AA, et al. Among authors: burra p. BMC Cancer. 2010 May 11;10:190. doi: 10.1186/1471-2407-10-190. BMC Cancer. 2010. PMID: 20459775 Free PMC article. Clinical Trial.

2

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.

Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, Burra P, Fagiuoli S, Farinati F, Rugge M, D'Amico DF. Cillo U, et al. Among authors: burra p. Ann Surg. 2004 Feb;239(2):150-9. doi: 10.1097/01.sla.0000109146.72827.76. Ann Surg. 2004. PMID: 14745321 Free PMC article.

3

Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft.

Loreno M, Bo P, Senzolo M, Cillo U, Naoumov N, Burra P. Loreno M, et al. Among authors: burra p. Transpl Int. 2005 Jan;17(11):730-4. doi: 10.1007/s00147-004-0785-5. Epub 2004 Nov 26. Transpl Int. 2005. PMID: 15717218 Free article.

4

Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease.

Targhetta S, Villamil F, Inturri P, Pontisso P, Fagiuoli S, Cillo U, Cecchetto A, Gianni S, Naccarato R, Burra P. Targhetta S, et al. Among authors: burra p. World J Gastroenterol. 2006 Mar 21;12(11):1706-12. doi: 10.3748/wjg.v12.i11.1706. World J Gastroenterol. 2006. PMID: 16586538 Free PMC article.

5

Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.

Cillo U, Vitale A, Brolese A, Zanus G, Neri D, Valmasoni M, Bonsignore P, Grigoletto F, Burra P, Farinati F, D'Amico DF. Cillo U, et al. Among authors: burra p. J Surg Oncol. 2007 Mar 1;95(3):213-20. doi: 10.1002/jso.20641. J Surg Oncol. 2007. PMID: 17066432

6

A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation.

Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs AK, Neri D, Zanus G, Boccagni P, Burra P, D'Amico DF. Norberto L, et al. Among authors: burra p. Liver Transpl. 2007 Sep;13(9):1272-8. doi: 10.1002/lt.21083. Liver Transpl. 2007. PMID: 17370331 Free article. Clinical Trial.

7

Influence of steroids on HCV recurrence after liver transplantation: A prospective study.

Vivarelli M, Burra P, La Barba G, Canova D, Senzolo M, Cucchetti A, D'Errico A, Guido M, Merenda R, Neri D, Zanello M, Giannini FM, Grazi GL, Cillo U, Pinna AD. Vivarelli M, et al. Among authors: burra p. J Hepatol. 2007 Dec;47(6):793-8. doi: 10.1016/j.jhep.2007.07.023. Epub 2007 Sep 24. J Hepatol. 2007. PMID: 17928091 Clinical Trial.

8

Bile duct stones and casts after liver transplantation: Different entities but similar prevention strategy?

Cillo U, Burra P, Norberto L, D'Amico D. Cillo U, et al. Among authors: burra p. Liver Transpl. 2008 Oct;14(10):1400-3. doi: 10.1002/lt.21628. Liver Transpl. 2008. PMID: 18825732 Free article. No abstract available.

9

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.

Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, Angeli P, Cillo U. Vitale A, et al. Among authors: burra p. Hepatology. 2010 Jan;51(1):165-73. doi: 10.1002/hep.23260. Hepatology. 2010. PMID: 19877181 Free article.

10

Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.

Vitale A, D'Amico F, Frigo AC, Grigoletto F, Brolese A, Zanus G, Neri D, Carraro A, D'Amico FE, Burra P, Russo F, Angeli P, Cillo U. Vitale A, et al. Among authors: burra p. Ann Surg Oncol. 2010 Sep;17(9):2290-302. doi: 10.1245/s10434-010-0993-4. Epub 2010 Mar 9. Ann Surg Oncol. 2010. PMID: 20217249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

531 results

Search Page